74527-0022 MARGENZA - CanMED: NDC

Product NDC:

74527-0022

Brand Name:

MARGENZA

Generic Name:

margetuximab-cmkb

Dosage Form Name:

INJECTION, SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: MARGETUXIMAB

Strength: 25.0

Unit: mg/mL

Packages:

Code: 74527-0022-02

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-02) / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)

Effective Date: Jan. 15, 2021

Discontinued:

Code: 74527-0022-03

Description: 4 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-03) / 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)

Effective Date: Jan. 15, 2021

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox